Wu Hao, Xia Lei, Liu Chunli
Shandong Public Health Clinical Center, Jinan, 250100, People's Republic of China.
Public Health Clinical Center Affiliated to Shandong University, Jinan, 250100, People's Republic of China.
J Inflamm Res. 2025 Aug 18;18:11217-11244. doi: 10.2147/JIR.S541159. eCollection 2025.
Heart failure (HF) and cardiac fibrosis constitute a substantial portion of the global cardiovascular disease (CVD) burden and are significant contributors to morbidity and mortality. Several mechanisms are involved in the pathogenesis of HF and cardiac fibrosis, with many studies recognizing apoptosis as a central player in their progression. Apoptosis is a conserved biological process directly regulated by extrinsic and intrinsic stimuli. Non-coding RNAs (ncRNAs) exert critical regulatory functions in gene expression and apoptosis, and their dysregulation may trigger excessive apoptosis, leading to cardiac fibrosis and HF. The current work is structured in two sections. The first section focuses on the role of ncRNAs dysregulation in cardiomyocyte apoptosis. In the final section, we emphasize that inhibiting pro-apoptotic microRNAs (miRNAs) through diverse therapeutic strategies, such as stem cell-derived exosomes and herbal medicine, may attenuate excessive apoptosis and represent a promising approach for the treatment of cardiac fibrosis and HF.
心力衰竭(HF)和心脏纤维化占全球心血管疾病(CVD)负担的很大一部分,是发病率和死亡率的重要促成因素。HF和心脏纤维化的发病机制涉及多种机制,许多研究认为细胞凋亡是其进展的核心因素。细胞凋亡是一个由外在和内在刺激直接调节的保守生物学过程。非编码RNA(ncRNAs)在基因表达和细胞凋亡中发挥关键调节功能,其失调可能引发过度细胞凋亡,导致心脏纤维化和HF。当前的工作分为两个部分。第一部分重点关注ncRNAs失调在心肌细胞凋亡中的作用。在最后一部分,我们强调通过多种治疗策略,如干细胞衍生的外泌体和草药,抑制促凋亡微小RNA(miRNAs),可能会减轻过度细胞凋亡,并代表一种治疗心脏纤维化和HF的有前景的方法。
2025-1
Arch Ital Urol Androl. 2025-6-30
2025-1
Biochem Pharmacol. 2024-8
J Control Release. 2024-6
Cell Death Differ. 2024-4